Bennett: I don’t know how much I earned on Soluto

Economy Minister Naftali Bennett: My holdings are managed by a blind trust, but I've promised the employees of my office a day of fun at my expense.

"I've been asked how much I made," said Minister of the Economy Naftali Bennett on his Facebook in response to questions about how much he made from the sale of Soluto Ltd., where he briefly served as CEO. "In truth, I don’t know, and apparently I should not know, because my holdings are managed by a blind trust, but I've promised the employees of my office a day of fun at my expense."

Bennett added, "Congratulations to Soluto and its founder and CEO Tomer Dvir. You succeeded, and you're staying to grow in Israel."

As for the sale, Bennett wrote, "It's being said that the sale of a company is bad for the Israeli economy (vis-à-vis economic growth). I don’t agree, because it greatly depends. For now, Soluto's product will be exposed to many new users worldwide. Soluto's employees will be exposed to new R&D and marketing methods, which will improve their skills. I believe (but I am not certain) that more good jobs will be created in Israel. I also bet that Soluto's people will found at least 3-4 new companies."

Published by Globes [online], Israel business news - www.globes-online.com - on November 3, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Yaron Daniely Replacing Ritalin

Alcobra has had two successful Nasdaq offerings this year as it develops an ADHD treatment with fewer side effects.

Twitter Facebook Linkedin RSS Newsletters גלובס